David Risinger, Cellarity CFO
A top Morgan Stanley sell-side analyst makes the jump from outside player to biotech C-suite insider
David Risinger spent more than 20 years observing the biopharma scene from the outside, spending the last 12 years at Morgan Stanley and ending as …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
